A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

Liver Diseases Clinical Trial

Official title:

A Quasi Experimental Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05088044
• Other study ID #: ILBS-Liver Disease-01
• Status: Recruiting
• Phase: N/A
• Start date: November 11, 2021
• Est. completion date: April 15, 2022

Study information

• Verified date: October 2021
• Source: Institute of Liver and Biliary Sciences, India
• Contact: Anjali Gautam, BSc
• Phone: 01146300000
• Email: anjaligautam.9524[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study nurses will be taught regarding Modified Early Warning Score and how to mark the involved physiological parameters in the MEWS chart and then scoring will be given i.e MEWS score and according to the score intervention would be taken by nurses by communicating with other health team members. this scoring will allow nurses to assess early deterioration and early ICU admission and at last nurses will be asked regarding the barriers or facilitators they faced while performing MEWS score.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 82
• Est. completion date: April 15, 2022
• Est. primary completion date: April 15, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 60 Years

Eligibility

Inclusion Criteria:

• registered nurses working in general, semi-private and private ward nurses willing to participate

Exclusion Criteria:

• registered nurses who will not be present at the time of data collection. pull out staffs.

Related Conditions & MeSH terms

• Liver Diseases

Intervention

Other:
• training porogram
training on modified early warning signs will be given to staff nurses and they will be asked to mark physiological parameters on MEWS chart and identify detrioration

Locations

Country	Name	City	State
India	Institute of Liver & Biliary Sciences	New Delhi	Delhi

Sponsors (1)

Lead Sponsor	Collaborator
Institute of Liver and Biliary Sciences, India

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	to assess the impact of MEWS on competency and self-efficacy of nurses before and after implementing MEWS	pre-test would be taken to assess previous level and post-test to measure the change in competency	7 days